Full Circle Healthcare: What Is Supply Chain 4.0?

 

What are the latest advancements in technology that are advancing today’s healthcare system’s supply chains? Leonard Gutierrez, Project Manager for Medsphere-HealthLine, provided his take on what’s driving innovation in supply chain management today.

Gutierrez sees data as an essential factor in this equation. As more robust systems operate supply management, the data gathered and analyzed helps guide ordering decisions to save money and ensure the right locations receive the right products when they need them.

“Automating supply chain operations in healthcare can be a challenge to this day,” Gutierrez said.

Moving processes to cloud-based computing is one advancement that excites Gutierrez. This move towards cloud-based operations frees up hospital resources, so they don’t have to manage the back end of the supply-chain system. A cloud-based system removes complexity for hospitals.

“It frees up capital expenditures, because healthcare organizations no longer need to maintain and upgrade certain computer equipment and data storage,” Gutierrez said.

While people are familiar with package tracking, today’s supply chain technologies allow for package tracking from a healthcare’s receiving area through department delivery. This type of advancement can save departments money in lost/misplaced packages.

And improved technologies also offer ways for large healthcare networks to access inventory across multiple hospitals, better utilize the inventory they have and reduce unnecessary ordering.

For the latest news, videos, and podcasts in the Healthcare Industry, be sure to subscribe to our industry publication.

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

Recent Episodes

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

As cancer immunotherapy continues to reshape treatment landscapes, fine-tuning T-cell responses has become a critical frontier. Recent advances in 3D organoid models and high-content imaging are enabling scientists to closely mimic patient-specific tumor environments—unlocking insights into how T cells behave, respond, and falter under immune checkpoint blockade. With over 4,000 immune modulators in clinical…

As immunotherapy revolutionizes cancer treatment, the need for physiologically relevant preclinical models becomes more urgent than ever. Despite the success of immune checkpoint inhibitors, a large majority of patients fail to achieve long-lasting responses, prompting researchers to explore more complex and predictive assays. The cancer immunity cycle, first described in 2013, remains a central framework…